<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Strategy Shares Nasdaq 7 Handl Index Etf — News on 6ix</title>
    <link>https://6ix.com/company/strategy-shares-nasdaq-7-handl-index-etf</link>
    <description>Latest news and press releases for Strategy Shares Nasdaq 7 Handl Index Etf on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Fri, 13 Mar 2026 04:00:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/strategy-shares-nasdaq-7-handl-index-etf" rel="self" type="application/rss+xml" />
    <item>
      <title>Weave Named Exclusive Patient Engagement Platform Endorsed for American Dental Association Members</title>
      <link>https://6ix.com/company/strategy-shares-nasdaq-7-handl-index-etf/news/weave-named-exclusive-patient-engagement-platform-endorsed-for-american-dental-association-members-39</link>
      <guid isPermaLink="true">https://6ix.com/company/strategy-shares-nasdaq-7-handl-index-etf/news/weave-named-exclusive-patient-engagement-platform-endorsed-for-american-dental-association-members-39</guid>
      <pubDate>Fri, 13 Mar 2026 04:00:00 GMT</pubDate>
      <description>LEHI, Utah--(BUSINESS WIRE)-- Weave (NYSE: WEAV), a leading all-in-one customer experience platform for small and medium-sized healthcare businesses, today</description>
    </item>
    <item>
      <title>UroGen Applauds BCAN’s New Faces of Bladder Cancer Report Highlighting Recurrence Burden and Fear of Recurrence</title>
      <link>https://6ix.com/company/strategy-shares-nasdaq-7-handl-index-etf/news/urogen-applauds-bcans-new-faces-of-bladder-cancer-report-highlighting-recurrence-burden-and-fear-of-recurrence-27</link>
      <guid isPermaLink="true">https://6ix.com/company/strategy-shares-nasdaq-7-handl-index-etf/news/urogen-applauds-bcans-new-faces-of-bladder-cancer-report-highlighting-recurrence-burden-and-fear-of-recurrence-27</guid>
      <pubDate>Fri, 13 Mar 2026 04:00:00 GMT</pubDate>
      <description>National survey of more than 1,100 bladder cancer patients finds nearly 80% report fear of recurrence, rising above 90% among patients under 50Many</description>
    </item>
    <item>
      <title>Covering Millions of Crypto Users, UTime Signs Non-Binding Letter of Intent to Acquire Data Platform “Feixiaohao” for Web3 Infrastructure Expansion</title>
      <link>https://6ix.com/company/strategy-shares-nasdaq-7-handl-index-etf/news/covering-millions-of-crypto-users-utime-signs-non-binding-letter-of-intent-to-acquire-data-platform-feixiaohao-for-web3-infrastructure-expansion-11</link>
      <guid isPermaLink="true">https://6ix.com/company/strategy-shares-nasdaq-7-handl-index-etf/news/covering-millions-of-crypto-users-utime-signs-non-binding-letter-of-intent-to-acquire-data-platform-feixiaohao-for-web3-infrastructure-expansion-11</guid>
      <pubDate>Fri, 13 Mar 2026 04:00:00 GMT</pubDate>
      <description>SHENZHEN, China, March 13, 2026 (GLOBE NEWSWIRE) -- UTime Limited (Nasdaq: WTO), a global technology company engaged in the design, development, and</description>
    </item>
    <item>
      <title>Sprinklr Named a Leader in the 2026 Gartner® Magic Quadrant™ for Voice of the Customer Platforms</title>
      <link>https://6ix.com/company/strategy-shares-nasdaq-7-handl-index-etf/news/sprinklr-named-a-leader-in-the-2026-gartnerr-magic-quadranttm-for-voice-of-the-customer-platforms-37</link>
      <guid isPermaLink="true">https://6ix.com/company/strategy-shares-nasdaq-7-handl-index-etf/news/sprinklr-named-a-leader-in-the-2026-gartnerr-magic-quadranttm-for-voice-of-the-customer-platforms-37</guid>
      <pubDate>Fri, 13 Mar 2026 04:00:00 GMT</pubDate>
      <description>NEW YORK--(BUSINESS WIRE)-- Sprinklr (NYSE: CXM), the definitive, AI-native platform for Unified Customer Experience Management (Unified-CXM), today</description>
    </item>
    <item>
      <title>Xtra-Gold Announces 2026 Normal Course Issuer Bid and Results of 2025 Bid</title>
      <link>https://6ix.com/company/strategy-shares-nasdaq-7-handl-index-etf/news/xtra-gold-announces-2026-normal-course-issuer-bid-and-results-of-2025-bid-38</link>
      <guid isPermaLink="true">https://6ix.com/company/strategy-shares-nasdaq-7-handl-index-etf/news/xtra-gold-announces-2026-normal-course-issuer-bid-and-results-of-2025-bid-38</guid>
      <pubDate>Fri, 13 Mar 2026 04:00:00 GMT</pubDate>
      <description>Toronto, Ontario--(Newsfile Corp. - March 13, 2026) - Xtra-Gold Resources Corp. (TSX: XTG) (OTCQB: XTGRF) (&quot;Xtra- Gold&quot; or the &quot;Company&quot;) is pleased to</description>
    </item>
    <item>
      <title>Oxford Lane Capital Corp. Prices Preferred Stock Offering</title>
      <link>https://6ix.com/company/strategy-shares-nasdaq-7-handl-index-etf/news/oxford-lane-capital-corp-prices-preferred-stock-offering-20</link>
      <guid isPermaLink="true">https://6ix.com/company/strategy-shares-nasdaq-7-handl-index-etf/news/oxford-lane-capital-corp-prices-preferred-stock-offering-20</guid>
      <pubDate>Fri, 13 Mar 2026 04:00:00 GMT</pubDate>
      <description>GREENWICH, Conn., March 13, 2026 (GLOBE NEWSWIRE) -- Oxford Lane Capital Corp. (Nasdaq GS: OXLC, OXLCP, OXLCL, OXLCO, OXLCZ, OXLCN, OXLCI and OXLCG) (the</description>
    </item>
    <item>
      <title>Origin Materials Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Conference Call</title>
      <link>https://6ix.com/company/strategy-shares-nasdaq-7-handl-index-etf/news/origin-materials-announces-fourth-quarter-and-full-year-2025-earnings-release-date-and-conference-call-43</link>
      <guid isPermaLink="true">https://6ix.com/company/strategy-shares-nasdaq-7-handl-index-etf/news/origin-materials-announces-fourth-quarter-and-full-year-2025-earnings-release-date-and-conference-call-43</guid>
      <pubDate>Fri, 13 Mar 2026 04:00:00 GMT</pubDate>
      <description>WEST SACRAMENTO, Calif.--(BUSINESS WIRE)-- Origin Materials, Inc. (“Origin,” “Origin Materials,” or “the Company”) (Nasdaq: ORGN, ORGNW), today announced</description>
    </item>
    <item>
      <title>SGN Announces BlockchAIn Has Signed LOI for 5 MW AI Infrastructure Deployment, Over $100 Million in Expected Contract Value During Initial Term</title>
      <link>https://6ix.com/company/strategy-shares-nasdaq-7-handl-index-etf/news/sgn-announces-blockchain-has-signed-loi-for-5-mw-ai-infrastructure-deployment-over-dollar100-million-in-expected-contract-value-during-initial-term-7</link>
      <guid isPermaLink="true">https://6ix.com/company/strategy-shares-nasdaq-7-handl-index-etf/news/sgn-announces-blockchain-has-signed-loi-for-5-mw-ai-infrastructure-deployment-over-dollar100-million-in-expected-contract-value-during-initial-term-7</guid>
      <pubDate>Fri, 13 Mar 2026 04:00:00 GMT</pubDate>
      <description>Scottsdale, AZ, March 13, 2026 (GLOBE NEWSWIRE) -- Signing Day Sports, Inc. (“Signing Day Sports”, “SGN” or the “Company”) (NYSE American: SGN), in connection</description>
    </item>
    <item>
      <title>First Andes Silver Announces New U.S. Stock Symbol</title>
      <link>https://6ix.com/company/strategy-shares-nasdaq-7-handl-index-etf/news/first-andes-silver-announces-new-us-stock-symbol-33</link>
      <guid isPermaLink="true">https://6ix.com/company/strategy-shares-nasdaq-7-handl-index-etf/news/first-andes-silver-announces-new-us-stock-symbol-33</guid>
      <pubDate>Fri, 13 Mar 2026 04:00:00 GMT</pubDate>
      <description>Vancouver, British Columbia--(Newsfile Corp. - March 13, 2026) - FIRST ANDES SILVER LTD. (TSXV: FAS) (OTC: FASLF) (FSE: 9TZ0) (&quot;First Andes&quot; or the &quot;Company&quot;)</description>
    </item>
    <item>
      <title>Lifeward Receives Shareholder Approval to Close on Strategic Partnership with Oramed—Creating Diversified Biomedical Company</title>
      <link>https://6ix.com/company/strategy-shares-nasdaq-7-handl-index-etf/news/lifeward-receives-shareholder-approval-to-close-on-strategic-partnership-with-oramedcreating-diversified-biomedical-company-14</link>
      <guid isPermaLink="true">https://6ix.com/company/strategy-shares-nasdaq-7-handl-index-etf/news/lifeward-receives-shareholder-approval-to-close-on-strategic-partnership-with-oramedcreating-diversified-biomedical-company-14</guid>
      <pubDate>Fri, 13 Mar 2026 04:00:00 GMT</pubDate>
      <description>Positions Lifeward as a diversified biomedical innovation company with clear path to profitability Integration of Oramed’s POD™ oral delivery technology</description>
    </item>
    <item>
      <title>Wolfspeed Appoints Silicon Carbide Industry Veteran Daihui Yu as Regional President, Greater China</title>
      <link>https://6ix.com/company/strategy-shares-nasdaq-7-handl-index-etf/news/wolfspeed-appoints-silicon-carbide-industry-veteran-daihui-yu-as-regional-president-greater-china-40</link>
      <guid isPermaLink="true">https://6ix.com/company/strategy-shares-nasdaq-7-handl-index-etf/news/wolfspeed-appoints-silicon-carbide-industry-veteran-daihui-yu-as-regional-president-greater-china-40</guid>
      <pubDate>Fri, 13 Mar 2026 04:00:00 GMT</pubDate>
      <description>DURHAM, N.C.--(BUSINESS WIRE)-- Wolfspeed is pleased to announce the appointment of Daihui Yu as regional president for Greater China, effective March 16,</description>
    </item>
    <item>
      <title>ESGold Appoints Veteran Capital Markets Executive Jason Tong as Chief Financial Officer</title>
      <link>https://6ix.com/company/strategy-shares-nasdaq-7-handl-index-etf/news/esgold-appoints-veteran-capital-markets-executive-jason-tong-as-chief-financial-officer-35</link>
      <guid isPermaLink="true">https://6ix.com/company/strategy-shares-nasdaq-7-handl-index-etf/news/esgold-appoints-veteran-capital-markets-executive-jason-tong-as-chief-financial-officer-35</guid>
      <pubDate>Fri, 13 Mar 2026 04:00:00 GMT</pubDate>
      <description>CFO with TSX, TSXV and Nasdaq experience joins leadership team as ESGold strengthens corporate structure ahead of planned gold and silver production in 2026</description>
    </item>
    <item>
      <title>SEALSQ and Parrot Expand Their Strategic Partnership: Parrot to Integrate SEALSQ Post-Quantum Cryptography into Its Next Generation of Secure Drones</title>
      <link>https://6ix.com/company/strategy-shares-nasdaq-7-handl-index-etf/news/sealsq-and-parrot-expand-their-strategic-partnership-parrot-to-integrate-sealsq-post-quantum-cryptography-into-its-next-generation-of-secure-drones-17</link>
      <guid isPermaLink="true">https://6ix.com/company/strategy-shares-nasdaq-7-handl-index-etf/news/sealsq-and-parrot-expand-their-strategic-partnership-parrot-to-integrate-sealsq-post-quantum-cryptography-into-its-next-generation-of-secure-drones-17</guid>
      <pubDate>Fri, 13 Mar 2026 04:00:00 GMT</pubDate>
      <description>Paris, France / Geneva, Switzerland , March 13, 2026 (GLOBE NEWSWIRE) -- Parrot CEO &amp; founder Henri Seydoux together with SEALSQ General Manager Bernard Vian</description>
    </item>
    <item>
      <title>Two Major Shows Added: Turnpike Troubadours and AJR Join VENU’s Ford Amphitheater 2026 Lineup</title>
      <link>https://6ix.com/company/strategy-shares-nasdaq-7-handl-index-etf/news/two-major-shows-added-turnpike-troubadours-and-ajr-join-venus-ford-amphitheater-2026-lineup-12</link>
      <guid isPermaLink="true">https://6ix.com/company/strategy-shares-nasdaq-7-handl-index-etf/news/two-major-shows-added-turnpike-troubadours-and-ajr-join-venus-ford-amphitheater-2026-lineup-12</guid>
      <pubDate>Fri, 13 Mar 2026 04:00:00 GMT</pubDate>
      <description>COLORADO SPRINGS, Colo.--(BUSINESS WIRE)-- Venu Holding Corporation (&quot;VENU&quot; or the &quot;Company&quot;) (NYSE AMERICAN: VENU), owner, operator, and developer of</description>
    </item>
    <item>
      <title>Beyond Oil Announces Results of Meeting of Shareholders</title>
      <link>https://6ix.com/company/strategy-shares-nasdaq-7-handl-index-etf/news/beyond-oil-announces-results-of-meeting-of-shareholders-6</link>
      <guid isPermaLink="true">https://6ix.com/company/strategy-shares-nasdaq-7-handl-index-etf/news/beyond-oil-announces-results-of-meeting-of-shareholders-6</guid>
      <pubDate>Fri, 13 Mar 2026 04:00:00 GMT</pubDate>
      <description>VANCOUVER, British Columbia, March 13, 2026 (GLOBE NEWSWIRE) -- Beyond Oil Ltd. (TSX: BOIL) (OTCQB: BEOLF) (“Beyond Oil” or the “Company”), a food-tech</description>
    </item>
    <item>
      <title>Elutia Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)</title>
      <link>https://6ix.com/company/strategy-shares-nasdaq-7-handl-index-etf/news/elutia-announces-grants-of-inducement-awards-under-nasdaq-listing-rule-5635c4-31</link>
      <guid isPermaLink="true">https://6ix.com/company/strategy-shares-nasdaq-7-handl-index-etf/news/elutia-announces-grants-of-inducement-awards-under-nasdaq-listing-rule-5635c4-31</guid>
      <pubDate>Fri, 13 Mar 2026 04:00:00 GMT</pubDate>
      <description>GAITHERSBURG, Md., March 13, 2026 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (&quot;Elutia&quot; or the &quot;Company&quot;), a pioneer in drug-eluting biomatrix</description>
    </item>
    <item>
      <title>MicroCloud Hologram Inc. (NASDAQ: HOLO) 2025 Annual Performance Forecast: Investment Income Fluctuations Lead to Annual Loss, Core Business Maintains Steady Growth</title>
      <link>https://6ix.com/company/strategy-shares-nasdaq-7-handl-index-etf/news/microcloud-hologram-inc-nasdaq-holo-2025-annual-performance-forecast-investment-income-fluctuations-lead-to-annual-loss-core-business-maintains-steady-growth-4</link>
      <guid isPermaLink="true">https://6ix.com/company/strategy-shares-nasdaq-7-handl-index-etf/news/microcloud-hologram-inc-nasdaq-holo-2025-annual-performance-forecast-investment-income-fluctuations-lead-to-annual-loss-core-business-maintains-steady-growth-4</guid>
      <pubDate>Fri, 13 Mar 2026 04:00:00 GMT</pubDate>
      <description>SHENZHEN, China, March 13, 2026 (GLOBE NEWSWIRE) -- MicroCloud Hologram Inc. (NASDAQ: HOLO), (&quot;HOLO&quot; or the &quot;Company&quot;), a technology service provider, has</description>
    </item>
    <item>
      <title>Equillium Announces $35 Million Financing with RA Capital Management</title>
      <link>https://6ix.com/company/strategy-shares-nasdaq-7-handl-index-etf/news/equillium-announces-dollar35-million-financing-with-ra-capital-management-8</link>
      <guid isPermaLink="true">https://6ix.com/company/strategy-shares-nasdaq-7-handl-index-etf/news/equillium-announces-dollar35-million-financing-with-ra-capital-management-8</guid>
      <pubDate>Fri, 13 Mar 2026 04:00:00 GMT</pubDate>
      <description>Capital strengthens the advancement of EQ504 through key clinical milestones Anticipated net proceeds, along with existing cash and cash equivalents, expected</description>
    </item>
    <item>
      <title>SunPower Completes the Integration of Sunder Energy</title>
      <link>https://6ix.com/company/strategy-shares-nasdaq-7-handl-index-etf/news/sunpower-completes-the-integration-of-sunder-energy-14</link>
      <guid isPermaLink="true">https://6ix.com/company/strategy-shares-nasdaq-7-handl-index-etf/news/sunpower-completes-the-integration-of-sunder-energy-14</guid>
      <pubDate>Fri, 13 Mar 2026 04:00:00 GMT</pubDate>
      <description>Integration Strengthens New Engine of Growth, Quality Standards, and Gains U.S. No 4 Spot OREM, Utah, March 13, 2026 (GLOBE NEWSWIRE) -- SunPower Inc.</description>
    </item>
    <item>
      <title>bioAffinity Technologies Announces Record 2025 Revenue and Unit Sales for Flagship Lung Cancer Diagnostic CyPath® Lung</title>
      <link>https://6ix.com/company/strategy-shares-nasdaq-7-handl-index-etf/news/bioaffinity-technologies-announces-record-2025-revenue-and-unit-sales-for-flagship-lung-cancer-diagnostic-cypathr-lung-36</link>
      <guid isPermaLink="true">https://6ix.com/company/strategy-shares-nasdaq-7-handl-index-etf/news/bioaffinity-technologies-announces-record-2025-revenue-and-unit-sales-for-flagship-lung-cancer-diagnostic-cypathr-lung-36</guid>
      <pubDate>Fri, 13 Mar 2026 04:00:00 GMT</pubDate>
      <description>Laboratory business streamlined in 2025 to focus on profitable diagnostic testing services including the Company’s high-value CyPath® Lung test Number of</description>
    </item>
  </channel>
</rss>